PYC Therapeutics Limited (PYC.AX)
AUD 1.08
(8.0%)
AUD 1.08
(8.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 22.05 Million AUD | 39.56% |
| 2023 | 15.8 Million AUD | -1.47% |
| 2022 | 16.04 Million AUD | 421.83% |
| 2021 | 3.07 Million AUD | 28.33% |
| 2020 | 2.39 Million AUD | 0.0% |
| 2019 | - AUD | -100.0% |
| 2018 | 48.46 Thousand AUD | -98.25% |
| 2017 | 2.76 Million AUD | 256659.57% |
| 2016 | 1076.00 AUD | -99.87% |
| 2015 | 829.11 Thousand AUD | 12.14% |
| 2014 | 739.39 Thousand AUD | 3.86% |
| 2013 | 711.89 Thousand AUD | -62.89% |
| 2012 | 1.91 Million AUD | -18.66% |
| 2011 | 2.35 Million AUD | 295.56% |
| 2010 | 596.25 Thousand AUD | -53.23% |
| 2009 | 1.27 Million AUD | 1304.86% |
| 2008 | 90.75 Thousand AUD | -67.05% |
| 2007 | 275.38 Thousand AUD | 0.0% |
| 2006 | - AUD | -100.0% |
| 2005 | 52.55 Thousand AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 8.9 Million AUD | 0.0% |
| 2024 Q4 | 13.15 Million AUD | 0.0% |
| 2023 Q4 | 12.33 Million AUD | 0.0% |
| 2023 FY | 15.8 Million AUD | -1.47% |
| 2023 Q2 | 3.47 Million AUD | 0.0% |
| 2022 FY | 16.04 Million AUD | 421.83% |
| 2022 Q4 | 10.04 Million AUD | 0.0% |
| 2022 Q2 | 5.99 Million AUD | 0.0% |
| 2021 FY | 3.07 Million AUD | 28.33% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | 3.07 Million AUD | 0.0% |
| 2020 Q4 | 2.39 Million AUD | 0.0% |
| 2020 FY | 2.39 Million AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2019 Q4 | -250.00 AUD | 0.0% |
| 2019 FY | - AUD | -100.0% |
| 2019 Q2 | 250.00 AUD | 0.0% |
| 2018 Q2 | 40 Thousand AUD | 0.0% |
| 2018 FY | 48.46 Thousand AUD | -98.25% |
| 2018 Q4 | 8460.00 AUD | 0.0% |
| 2017 Q4 | 2475.00 AUD | 0.0% |
| 2017 FY | 2.76 Million AUD | 256659.57% |
| 2017 Q2 | 2.76 Million AUD | 0.0% |
| 2016 Q2 | 29.00 AUD | 0.0% |
| 2016 FY | 1076.00 AUD | -99.87% |
| 2016 Q4 | 1047.00 AUD | 0.0% |
| 2015 Q2 | 775.75 Thousand AUD | 0.0% |
| 2015 FY | 829.11 Thousand AUD | 12.14% |
| 2015 Q4 | 53.36 Thousand AUD | 0.0% |
| 2014 Q2 | 747.23 Thousand AUD | 0.0% |
| 2014 Q4 | -7847.00 AUD | 0.0% |
| 2014 FY | 739.39 Thousand AUD | 3.86% |
| 2013 Q3 | - AUD | -100.0% |
| 2013 Q2 | 98.05 Thousand AUD | -79.55% |
| 2013 Q1 | 479.59 Thousand AUD | 0.0% |
| 2013 FY | 711.89 Thousand AUD | -62.89% |
| 2013 Q4 | 613.83 Thousand AUD | 0.0% |
| 2012 Q4 | 479.59 Thousand AUD | 0.0% |
| 2012 Q2 | 479.59 Thousand AUD | -18.66% |
| 2012 Q3 | 479.59 Thousand AUD | 0.0% |
| 2012 FY | 1.91 Million AUD | -18.66% |
| 2012 Q1 | 589.63 Thousand AUD | 0.0% |
| 2011 FY | 2.35 Million AUD | 295.56% |
| 2011 Q2 | 589.63 Thousand AUD | 295.56% |
| 2011 Q3 | 589.63 Thousand AUD | 0.0% |
| 2011 Q4 | 589.63 Thousand AUD | 0.0% |
| 2011 Q1 | 149.06 Thousand AUD | 0.0% |
| 2010 Q1 | 318.73 Thousand AUD | 0.0% |
| 2010 FY | 596.25 Thousand AUD | -53.23% |
| 2010 Q4 | 149.06 Thousand AUD | 0.0% |
| 2010 Q2 | 149.06 Thousand AUD | -53.23% |
| 2010 Q3 | 149.06 Thousand AUD | 0.0% |
| 2009 Q1 | 22.68 Thousand AUD | 0.0% |
| 2009 Q2 | 318.73 Thousand AUD | 1304.86% |
| 2009 Q3 | 318.73 Thousand AUD | 0.0% |
| 2009 FY | 1.27 Million AUD | 1304.86% |
| 2009 Q4 | 318.73 Thousand AUD | 0.0% |
| 2008 Q4 | 22.68 Thousand AUD | 0.0% |
| 2008 FY | 90.75 Thousand AUD | -67.05% |
| 2008 Q1 | 68.84 Thousand AUD | 0.0% |
| 2008 Q2 | 22.68 Thousand AUD | -67.05% |
| 2008 Q3 | 22.68 Thousand AUD | 0.0% |
| 2007 Q3 | 68.84 Thousand AUD | 0.0% |
| 2007 FY | 275.38 Thousand AUD | 0.0% |
| 2007 Q4 | 68.84 Thousand AUD | 0.0% |
| 2007 Q2 | 68.84 Thousand AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 Q2 | - AUD | -100.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 FY | - AUD | -100.0% |
| 2006 Q1 | 13.13 Thousand AUD | 0.0% |
| 2005 Q3 | 13.13 Thousand AUD | 0.0% |
| 2005 Q2 | 13.13 Thousand AUD | 0.0% |
| 2005 FY | 52.55 Thousand AUD | 0.0% |
| 2005 Q4 | 13.13 Thousand AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -1169.383% |
| Acrux Limited | 5.09 Million AUD | -333.3% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -3565.434% |
| BTC Health Limited | 16.36 Thousand AUD | -134736.883% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -195.794% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | -91.709% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 74.983% |
| Biome Australia Limited | 13 Million AUD | -69.571% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | -529.237% |
| Memphasys Limited | 60 Thousand AUD | -36665.523% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 90.489% |
| Noxopharm Limited | 2.4 Million AUD | -819.032% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -494.212% |
| Race Oncology Limited | 4 Million AUD | -451.005% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -7272.075% |
| Starpharma Holdings Limited | 8.28 Million AUD | -166.128% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -14389.828% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | -448.837% |
| CSL Limited | 22.41 Billion AUD | 99.902% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 66.8% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -120311.103% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -23132.069% |
| Patrys Limited | 1.39 Million AUD | -1482.262% |
| Orthocell Limited | 5.31 Million AUD | -315.01% |
| Imugene Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -2372.621% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -852.622% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -129660.671% |
| Nanollose Limited | 12.5 Thousand AUD | -176360.395% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -1719.691% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | -395.41% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -1662.524% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 95.558% |
| Dimerix Limited | 583.47 Thousand AUD | -3680.659% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -4691.368% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -33424.793% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -4558.276% |
| Actinogen Medical Limited | 9.93 Million AUD | -122.115% |
| Immuron Limited | 4.9 Million AUD | -349.927% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -749.109% |